294 related articles for article (PubMed ID: 33265898)
1. Advances in Cardiovascular Biomarker Discovery.
Ghantous CM; Kamareddine L; Farhat R; Zouein FA; Mondello S; Kobeissy F; Zeidan A
Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33265898
[TBL] [Abstract][Full Text] [Related]
2. Statistical Methods for Identifying Biomarkers from miRNA Profiles of Cancers.
Namkung J
Methods Mol Biol; 2019; 1882():261-286. PubMed ID: 30378062
[TBL] [Abstract][Full Text] [Related]
3. Biomarker Discovery in Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
Przybycien-Szymanska MM; Ashley WW
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1453-64. PubMed ID: 25957908
[TBL] [Abstract][Full Text] [Related]
4. Heart disease, clinical proteomics and mass spectrometry.
Stanley BA; Gundry RL; Cotter RJ; Van Eyk JE
Dis Markers; 2004; 20(3):167-78. PubMed ID: 15502250
[TBL] [Abstract][Full Text] [Related]
5. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
Wang WX; Fardo DW; Jicha GA; Nelson PT
Mol Neurobiol; 2017 Dec; 54(10):8191-8202. PubMed ID: 27900678
[TBL] [Abstract][Full Text] [Related]
6. Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.
Kim SH; Weiß C; Hoffmann U; Borggrefe M; Akin I; Behnes M
Curr Pharm Biotechnol; 2017; 18(6):445-455. PubMed ID: 28571562
[TBL] [Abstract][Full Text] [Related]
7. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
[TBL] [Abstract][Full Text] [Related]
8. Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling.
Basso D; Padoan A; Laufer T; Aneloni V; Moz S; Schroers H; Pelloso M; Saiz A; Krapp M; Fogar P; Cornoldi P; Zambon CF; Rossi E; La Malfa M; Marotti A; Brefort T; Weis TM; Katus HA; Plebani M
Clin Biochem; 2017 Mar; 50(4-5):186-193. PubMed ID: 27847340
[TBL] [Abstract][Full Text] [Related]
9. Urine protein biomarkers for detection of cardiovascular disease and their use for the clinic.
Röthlisberger S; Pedroza-Diaz J
Expert Rev Proteomics; 2017 Dec; 14(12):1091-1103. PubMed ID: 29041828
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
Watson CJ; Gupta SK; O'Connell E; Thum S; Glezeva N; Fendrich J; Gallagher J; Ledwidge M; Grote-Levi L; McDonald K; Thum T
Eur J Heart Fail; 2015 Apr; 17(4):405-15. PubMed ID: 25739750
[TBL] [Abstract][Full Text] [Related]
11. Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
Kanuri SH; Ipe J; Kassab K; Gao H; Liu Y; Skaar TC; Kreutz RP
Atherosclerosis; 2018 Nov; 278():232-239. PubMed ID: 30336307
[TBL] [Abstract][Full Text] [Related]
12. Genetic markers: Potential candidates for cardiovascular disease.
Rather RA; Dhawan V
Int J Cardiol; 2016 Oct; 220():914-23. PubMed ID: 27416153
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of plasma miRNA biomarker signature panel for the detection of early HIV-1 infection.
Biswas S; Haleyurgirisetty M; Lee S; Hewlett I; Devadas K
EBioMedicine; 2019 May; 43():307-316. PubMed ID: 31005516
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care.
Di Pietro V; Yakoub KM; Scarpa U; Di Pietro C; Belli A
Front Neurol; 2018; 9():429. PubMed ID: 29963002
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA and Cardiovascular Diseases.
Çakmak HA; Demir M
Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel biomarker candidates for hypertrophic cardiomyopathy and other cardiovascular diseases leading to heart failure.
Rehulkova H; Rehulka P; Myslivcova Fucikova A; Stulik J; Pudil R
Physiol Res; 2016 Nov; 65(5):751-762. PubMed ID: 27429122
[TBL] [Abstract][Full Text] [Related]
17. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
18. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
Krintus M; Kozinski M; Kubica J; Sypniewska G
Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
[TBL] [Abstract][Full Text] [Related]
19. The discovery of protein biomarkers in pre-eclampsia: the promising role of mass spectrometry.
Dahabiyeh LA
Biomarkers; 2018 Nov; 23(7):609-621. PubMed ID: 29737875
[TBL] [Abstract][Full Text] [Related]
20. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
